Amgen Valuation Overview

AMGN -- USA Stock  

USD 202.77  0.97  0.48%

Amgen shows prevailing Real Value of $192.80275 per share. The current price of the firm is $202.77. At this time the firm appears to be over valued. Macroaxis approximates value of Amgen from analyzing the firm fundamentals such as Profit Margin of 10.19% and Return On Equity of 10.14% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor to go long with undervalued instruments and to trade away overvalued instruments since at some point assets prices and their ongoing real values will blend.
Valuation Drivers Correlation
Click cells to compare fundamentals   View All Correlations
Amgen Valuation Data Drivers
Net Income Per Employee    Enterprise Value    Market Capitalization    
Amgen Market Cap
Amgen is number one stock in market capitalization category among related companies. Market capitalization of Biotechnology industry is presently estimated at about 137.96 Billion. Amgen totals roughly 130.62 Billion in market capitalization claiming about 95% of stocks in Biotechnology industry.
Capitalization  Valuation  Total debt  Revenue  Workforce
Horizon     30 Days    Login   to change
Amgen is rated fourth in price to book category among related companies. It is number one stock in five year return category among related companies reporting about  0.24  of Five Year Return per Price to Book. The ratio of Price to Book to Five Year Return for Amgen is roughly  4.10 

Current Market Valuation

Amgen Valuation Boundaries

Over Valued
October 20, 2018
202.77
Market Value
Downside
188.63
192.80
Real Value
Target Odds
  
223.05
Upside
Amgen is not too risky asset. Calculation of real value of Amgen is based on 1 month time horizon. Increasing Amgen time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.

Valuation Basics

Amgen Enterprise Value Fundamentals

Quick Ratio2.94
Earnings Quarterly Growth6.70%
Revenue Growth4.30%
Payout Ratio133.15%
Enterprise Value To Ebitda10.90
Earnings Growth19.60%
Enterprise Value To Revenue5.88
Check also Trending Equities. Please also try Pair Correlation module to compare performance and examine historical correlation between any two equity instruments.
Search macroaxis.com